These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23600397)

  • 21. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 22. Methamphetamine: geographic areas and populations at risk, and emerging evidence for effective interventions.
    Degenhardt L; Baker A; Maher L
    Drug Alcohol Rev; 2008 May; 27(3):217-9. PubMed ID: 18368601
    [No Abstract]   [Full Text] [Related]  

  • 23. [Spontaneous recrudescence of psychotic diseases caused by methamphetamine (a stimulant): the stress type and the role of noradrenaline and dopamine systems].
    Aburai K; Ikemoto U; Goto K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Oct; 24(5):319-20. PubMed ID: 15658512
    [No Abstract]   [Full Text] [Related]  

  • 24. Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.
    Smirnova L; Hogberg HT; Leist M; Hartung T
    ALTEX; 2014; 31(2):129-56. PubMed ID: 24687333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The methamphetamine epidemic and dentistry.
    Klasser GD; Epstein JB
    Gen Dent; 2006; 54(6):431-9; quiz 440, 448. PubMed ID: 17134084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 27. A harmless high?
    Sammler EM; Foley PL; Lauder GD; Wilson SJ; Goudie AR; O'Riordan JI
    Lancet; 2010 Aug; 376(9742):742. PubMed ID: 20801405
    [No Abstract]   [Full Text] [Related]  

  • 28. Amphetamine neurotoxicity: accomplishments and remaining challenges.
    McCann UD; Ricaurte GA
    Neurosci Biobehav Rev; 2004 Jan; 27(8):821-6. PubMed ID: 15019431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current data on methamphetamine].
    Cottencin O; Rolland B; Guardia D; Karila L
    Rev Prat; 2012 May; 62(5):679-81. PubMed ID: 22730802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
    Dluzen DE
    Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk assessment of an essential element: manganese.
    Santamaria AB; Sulsky SI
    J Toxicol Environ Health A; 2010; 73(2):128-55. PubMed ID: 20077284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of Hypermanganesemia in Children Who Are Administered Parenteral Nutrition.
    Greene E; Shokur R; Brown L; Petros A; Raman S
    JPEN J Parenter Enteral Nutr; 2016 Aug; 40(6):766-7. PubMed ID: 27440414
    [No Abstract]   [Full Text] [Related]  

  • 33. Triple trouble: cognitive deficits from hepatitis C, HIV, and methamphetamine.
    van Gorp WG; Hinkin CH
    Neurology; 2005 Apr; 64(8):1328-9. PubMed ID: 15851716
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutual enhancement of central neurotoxicity induced by ketamine followed by methamphetamine.
    Ke JJ; Chen HI; Jen CJ; Kuo YM; Cherng CG; Tsai YP; Ho MC; Tsai CW; Yu L
    Toxicol Appl Pharmacol; 2008 Mar; 227(2):239-47. PubMed ID: 18076959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Manganese neurotoxicity: connecting the dots along the continuum of dysfunction.
    Martin CJ
    Neurotoxicology; 2006 May; 27(3):347-9. PubMed ID: 16337002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotoxicology: what can context teach us?
    Wright RO
    J Pediatr; 2008 Feb; 152(2):155-7. PubMed ID: 18206679
    [No Abstract]   [Full Text] [Related]  

  • 37. Toxic agents causing cerebellar ataxias.
    Manto M
    Handb Clin Neurol; 2012; 103():201-13. PubMed ID: 21827890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychiatric disorders. Multidisciplinary diagnosis and treatment].
    Luykx JJ; Wolters FJ; Vulink NC; van der Erf M; Wokke JH; Kahn RS
    Ned Tijdschr Geneeskd; 2009 Jan; 153(3):75-9. PubMed ID: 19235342
    [No Abstract]   [Full Text] [Related]  

  • 39. Methamphetamine and cardiovascular pathology: a review of the evidence.
    Kaye S; McKetin R; Duflou J; Darke S
    Addiction; 2007 Aug; 102(8):1204-11. PubMed ID: 17565561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will.
    Worth H; Rawstorne P
    Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.